Promising Results for Chemo-Free Immunotherapy in Early-Stage Triple-Negative Breast Cancer
Phase 2 trial shows potential for immunotherapy without chemo in early TNBC, especially with high TILs.
Sarcomas
1 article
Dual Checkpoint Inhibition Shows Promise in Rare Desmoid Tumors
Phase II trial reveals potential of ipilimumab and nivolumab combination in treating desmoid tumors